@article{oai:az.repo.nii.ac.jp:00005405,
 journal = {麻布大学雑誌, Journal of Azabu University},
 month = {Mar},
 note = {Untreated canine intranasal tumors have a poor prognosis. The median survival time of dogs with intranasal tumors when treated with hypofractionated radiotherapy alone does not typically exceed one year. In this retrospective study, we evaluated dogs treated with hypofractionated radiotherapy followed by surgical debulking. Among 18 dogs, four had stage I, one had stage II, five had stage III, and eight had stage IV tumors. Surgery was performed either immediately after the final radiation treatment or 1–2 months after radiotherapy. Following macroscopic tumor resection after surgery (p = 0.008), the timing of surgery ≥ one month postradiotherapy (p = 0.011) and the early tumor stage (I–III; p = 0.043) were potentially associated with a favorable progression-free survival. The median overall survival in the early stages was 26 months. Therefore, microscopic residual tumor resection should be considered one month after completion of hypofractionated radiotherapy for dogs with early-stage tumors., P(論文), 原著論文, application/pdf, ORIGINAL ARTICLE},
 pages = {11--17},
 title = {Combination Therapy of Hypofractionated Radiotherapy and Surgical Resection for Canine Intranasal Tumors},
 volume = {32},
 year = {2021}
}